Synthesis and anti-trypanosomal activity of novel 5-nitro-2-furaldehyde and 5-nitrothiophene-2-carboxaldehyde semicarbazone derivatives

Farmaco

Volumn 53, Issue 2, 1998, Pages 89-94

  Cerecetto, Hugo ^a   Di Maio, Rossanna ^a   Ibarruri, Gerardo ^a   Seoane, Gustavo ^a   Denicola, Ana ^b   Peluffo, Gonzalo ^b   Quijano, Celia ^b   Paulino, Margot ^a  

^a UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^b UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

Author keywords

5 Nitrofurfural and 5 nitrothiophene 2 carboxaldehyde derivatives; Anti trypanosomal activity; Semicarbazones

Indexed keywords

5 NITRO 2 FURALDEHYDE; ANTITRYPANOSOMAL AGENT; NIFURTIMOX; SEMICARBAZONE DERIVATIVE; THIOSEMICARBAZONE DERIVATIVE;

ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; INFRARED SPECTROMETRY; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; TRYPANOSOMA CRUZI;

ANIMALS; SEMICARBAZONES; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

EID: 0032469445     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(97)00011-6     Document Type: Article

References (26)

1. Z. Brener, Present status of chemotherapy and chemoprophylaxis of human trypanosomiasis in the western hemisphere, Pharmacol. Therap. 7 (1979) 71-78.
2. J.C. Messeder, L.W. Tinoco, J.D. Figueroa-Villar, E.M. Souza, R. Santa Rita, S.L. de Castro, Aromatic guanyl hydrazones: synthesis, structural and in vitro activity against Trypanosoma cruzi, Bioorg. Med. Chem. Lett., 5 (1995) 3079-3084.
3. R.H. Schirmer, J.G. Müller, R.L. Krauth-Siegel, Disulfide-reductase inhibitors as chemotherapeutic agents; the design of drugs for trypanosomiasis and malaria, Angew. Chem., Int. Ed. Engl. 34 (1995) 141-145.
4. W.E. Gutteridge, Chemotherapy of Chagas' disease: the present situation, Trop. Dis. Bull. 73 (1976) 699-704.
5. J.J. Marr and R. Docampo, Chemotherapy for Chagas' disease: A perspective of current therapy and considerations for future research, Rev. Infec. Dis. 8 (1986) 884-903.
6. A. Morello, The biochemistry of the mode of action of drugs and the detoxication mechanisms in Trypanosoma cruzi, Comp. Biochem. Physiol. 90C (1988) 1-12.
7. R. Nagel, Genotoxicity studies with two antichagasic drugs, Mutat. Res. 191 (1987) 17-20.
8. A.H. Fairlamb, Trypanothione metabolism and rational approaches to drug design, Biochem. Soc. Trans. 18 (1990) 717-720.
9. A.H. Fairlamb, P. Blackburn, P. Ulrich, B.T. Chait, A. Cerami, Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids, Science 227 (1985) 1485-1487.
10. A.H. Fairlamb, A. Cerami, Metabolism and functions of trypanothione in the kinetoplastida, Annu. Rev. Microbiol. 46 (1992) 695-729.
11. S.L. Shames, A.H. Fairlamb, A. Cerami, C.T. Walsh, Purification and characterization of trypanothione reductase from Crithidia fasciculata a newly discovered member of the family of disulfide-containing flavoprotein reductases, Biochemistry 25 (1986) 3519-3526.
12. A.H. Fairlamb, Novel biochemical pathways in parasitic protozoa, Parasitology 99S (1990) 93-112.
13. G.B. Henderson, A.H. Fairlamb, A. Cerami, Trypanothione dependent peroxide metabolism in Crithidia fasciculata and Trypanosoma brucei, Mol. Biochem. Parasitol. 24 (1987) 39-43.
14. J. Kuriyan, X.P. Kong, T.S.R. Krishna, R.M. Sweet, N.J. Murgolo, H. Field, A. Cerami, G.B. Henderson, X-ray structure of trypanothione reductase from Crithidia fasciculata at 2.4-Å resolution, Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 8764-8768.
15. W.N. Hunter, S. Bailey, J. Habash, S.J. Harrop, J.R. Helliwell, T. Aboyage-Kwarteng, K. Smith, A.H. Fairlamb, Active site of trypanothione reductase. A target for rational drug design, J. Mol. Biol. 227 (1992) 322-333.
16. 1-glutathionylspermidine disulfide at 0.28-nm resolution, Eur. J. Biochem. 213 (1993) 67-75.
17. O. Tapia, M. Paulino, F.M.L.G. Stamato, Computer assisted simulations and molecular graphics methods in molecular design. 1. Theory and applications to enzyme active-site directed drug design, Mol. Eng. 3 (1994) 377-414.
18. N. Hikichi, M. Paulino, M. Hansz, O. Tapia, A molecular dynamics study of glutathione reductase, Teochem. 335 (1995) 243-254.
19. G.B. Henderson, P. Ulrich, A.H. Fairlamb, I. Rosenberg, M. Pereira, M. Sela, A. Cerami, 'Subversive' substrates for the enzyme trypanothione disulfide reductase: Alternative approach to chemotherapy of Chagas disease, Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 5374-5378.
20. H. Cerecetto, B. Mester, S. Onetto, G. Seoane, M. González, F. Zinola, Formal potentials of new analogues of Nifurtimox: relationship to activity, Farmaco, 47 (1992) 1207-1213.
21. D.J. Hammond, B. Cover, W.E. Gutteridge, A novel series of chemical structures active in vitro against the trypomastigote form of Trypanosoma cruzi, Trans. R. Soc. Trop. Med. Hyg. 78 (1984) 91-95.
22. B. Mester, J. Elguero, R.M. Claramunt, S. Castanys, M.L. Mascaro, A. Osuma, M.J. Vilaplana, P. Molina, Activity against Trypanosoma cruzi of new analogues of Nifurtimox, Arch. Pharm. 320 (1987) 115-120.
23. L.A. Carpino, B.A. Carpino, A.G. Chester, R.W. Murray, A.A. Santilli, P.H. Terry, Org. Synth. Collect. 5 (1973) 168-170.
24. US Patent No. 2 610 181 (1952); Chem. Abstr. 47 (1953) 6980i.
25. D.D. Perrin, W.L.F. Armarego, Purification of Laboratory Chemicals, 3rd ed., Pergamon, Oxford, 1988.
26. A. Denicola, H. Rubbo, D. Rodríguez, R. Radi, Peroxynitrite-mediated cytotoxicity to Trypanosoma cruzi. Arch. Biochem. Biophys. 304 (1993) 279-286.